Indo US Bio-Tech Ltd Q1 FY2024-2025 Results: Summary
Revenue | ₹24.75Cr |
Net Profits | ₹3.17Cr |
Net Profit Margins | 12.81% |
Highlights
Revenue:
Indo US Bio-Tech Ltd’s revenue jumped 29.11% since last year same period to ₹24.75Cr in the Q1 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -35.16% fall in its revenue since last 3-months.
Net Profits:
Indo US Bio-Tech Ltd’s net profit jumped 33.76% since last year same period to ₹3.17Cr in the Q1 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -24.7% fall in its net profits since last 3-months.
Net Profit Margins:
Indo US Bio-Tech Ltd’s net profit margin jumped 3.6% since last year same period to 12.81% in the Q1 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 16.12% jump in its net profit margins since last 3-months.
